16-30902065-C-T
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001330.5(CTF1):c.145-13C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000511 in 1,448,502 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001330.5 intron
Scores
Clinical Significance
Conservation
Publications
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000922 AC: 14AN: 151898Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.000122 AC: 10AN: 82004 AF XY: 0.000128 show subpopulations
GnomAD4 exome AF: 0.0000463 AC: 60AN: 1296604Hom.: 0 Cov.: 30 AF XY: 0.0000454 AC XY: 29AN XY: 639366 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000922 AC: 14AN: 151898Hom.: 0 Cov.: 31 AF XY: 0.0000943 AC XY: 7AN XY: 74206 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The 145-13C>T variant (CTF1) has not been reported in the literature nor previou sly identified by our laboratory. This variant is located in the 3' splice regio n. Computational tools do not predict altered splicing; however, this informatio n is not predictive enough to rule out pathogenicity. Additional studies are nee ded to fully assess the clinical significance of the 145-13C>T variant. -
Dilated Cardiomyopathy, Dominant Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at